| Dr Joy Pamela Piccolino, PSYD, LP | |
|
12940 Harriet Ave S, Suite 250, Burnsville, MN 55337-2680 | |
| (952) 435-4074 | |
| (952) 435-6074 |
| Full Name | Dr Joy Pamela Piccolino |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 12940 Harriet Ave S, Burnsville, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225123946 | NPI | - | NPPES |
| 5572177-00 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | LP4179 (Minnesota) | Secondary |
| 103TC0700X | Psychologist - Clinical | LP4179 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joy Pamela Piccolino, PSYD, LP 12940 Harriet Ave S, Suite 250, Burnsville, MN 55337-2680 Ph: (952) 435-4074 | Dr Joy Pamela Piccolino, PSYD, LP 12940 Harriet Ave S, Suite 250, Burnsville, MN 55337-2680 Ph: (952) 435-4074 |
News Archive
On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
In 2010, the American Society of Anesthesiologists® (ASA®) introduced a mannequin-based simulation program to satisfy the American Board of Anesthesiology requirements for Maintenance of Certification in Anesthesiology (MOCA).
Compugen Ltd. announced today the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.
› Verified 1 days ago
Dr. Amy C. Patella, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2428 E 117th St, Burnsville, MN 55337 Phone: 612-444-3000 Fax: 612-444-9000 | |
Lauren K Rance, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 675 E Nicollet Blvd Ste 250, Burnsville, MN 55337 Phone: 952-993-3307 | |
Mr. Jere W Chapman, MA, LP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 14000 Fairview Dr, Burnsville, MN 55337 Phone: 952-993-8608 | |
David R Bradshaw, MED, LP Psychologist Medicare: Medicare Enrolled Practice Location: 14569 Grand Ave, Suite 200, Burnsville, MN 55306 Phone: 952-892-7690 Fax: 952-898-4930 | |
Dr. Jami Jeyn Hughes, PSY.D, BCBA-D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 201 W Travelers Trl Ste 212, Burnsville, MN 55337 Phone: 651-295-7440 Fax: 612-437-4499 | |
John M Gessner, MALP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2960 Judicial Rd, S 210, Burnsville, MN 55337 Phone: 952-224-2990 Fax: 952-224-2990 | |
Dorothy Eleanor Wintz, MA, LP Psychologist Medicare: Medicare Enrolled Practice Location: 1500 Mcandrews Rd W Ste 201, Burnsville, MN 55337 Phone: 952-892-8495 Fax: 952-892-8496 |